Literature DB >> 19233190

Regulation of myofibroblast differentiation by convergence of the Wnt and TGF-beta1/Smad signaling pathways.

Sarah Jane George.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19233190     DOI： 10.1016/j.yjmcc.2009.02.008

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  7 in total

1.  Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis.

Authors:  Su-Li Cheng; Jian-Su Shao; Linda R Halstead; Kathryn Distelhorst; Oscar Sierra; Dwight A Towler
Journal:  Circ Res       Date:  2010-05-20       Impact factor: 17.367

2.  Salinomycin and other polyether ionophores are a new class of antiscarring agent.

Authors:  Collynn F Woeller; Charles W O'Loughlin; Elisa Roztocil; Steven E Feldon; Richard P Phipps
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

Review 3.  Myofibroblasts.

Authors:  Biao Hu; Sem H Phan
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

4.  Wnt3a induces myofibroblast differentiation by upregulating TGF-β signaling through SMAD2 in a β-catenin-dependent manner.

Authors:  Jon M Carthy; Farshid S Garmaroudi; Zongshu Luo; Bruce M McManus
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

5.  Fibroblast-myofibroblast transition is differentially regulated by bronchial epithelial cells from asthmatic children.

Authors:  Stephen R Reeves; Tessa Kolstad; Tin-Yu Lien; Sarah Herrington-Shaner; Jason S Debley
Journal:  Respir Res       Date:  2015-02-13

6.  Activation of Wnt/β-catenin signalling is required for TGF-β/Smad2/3 signalling during myofibroblast proliferation.

Authors:  Liang Xu; Wen-Hui Cui; Wen-Cheng Zhou; De-Lin Li; Liu-Cheng Li; Ping Zhao; Xiao-Ting Mo; Zhihui Zhang; Jian Gao
Journal:  J Cell Mol Med       Date:  2017-02-28       Impact factor: 5.310

7.  The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology.

Authors:  Alison M Heffer; Jacob Proaño; Elisa Roztocil; Richard P Phipps; Steven E Feldon; Krystel R Huxlin; Patricia J Sime; Richard T Libby; Collynn F Woeller; Ajay E Kuriyan
Journal:  PLoS One       Date:  2019-09-17       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.